154 results on '"Lacout, C"'
Search Results
2. Quelles mesures adjuvantes associer à une corticothérapie orale prolongée dans le cadre des maladies inflammatoires ? Synthèse des recommandations françaises disponibles
3. Serum ferritin/C-reactive protein ratio is a simple and effective biomarker for diagnosing iron deficiency in the context of systemic inflammation.
4. Étude de comparaison des caractéristiques et de la survie de l’HLH dans une population âgée : OLD HLH
5. Vacuoles au sein des précurseurs myéloïdes médullaires dans le syndrome VEXAS : seuil et performances diagnostiques
6. Chauds comme un lapin
7. Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment
8. Caspases/NOX2 axis: a potential target to modulate macrophage polarization: 6.72
9. Une plaque particulièrement glissante
10. Évolution de la vitamine B12 plasmatique au cours des cancers solides sous traitement curatif ou palliatif
11. PREDEXIT : PREDnisone versus DEXamethasone in Immune Thrombocytopenia
12. Une rate INNOSANTE
13. A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
14. La ballade de la rate : promenons-nous vers le foie
15. Succès des inhibiteurs de JAK dans une nouvelle présentation de maladie auto-inflammatoire associée à JAK1
16. Case report : thrombopénie immunologique associée au CMV
17. Hemostasis and thrombosis in JAK2V617F-KI mice: PA 1.03–3
18. Hemostasis and thrombosis in JAK2V617F-KI mice: OC 58.5
19. Caractéristiques cliniques et évolution à long-terme des périartérite noueuses systémiques diagnostiquées depuis 2005
20. Élévation inexpliquée des D-dimères, penser au syndrome de Kasabach–Merritt
21. Érythème de Bazin : une manifestation rare de sarcoïdose
22. L’élévation persistante de la vitamine B12 plasmatique comme marqueur prédictif de cancer solide
23. Facteurs associés à la mortalité à J30 dans l’hémophagocytose lymphohistiocytaire chez l’adulte : construction d’un score de mortalité à partir d’une cohorte multicentrique de 170 patients et validation sur une cohorte de 118 patients
24. Risque infectieux de l’étoposide dans l’hémophagocytose lymphohistiocytaire de l’adulte
25. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines
26. Major effects of TPO delivered by a single injection of a recombinant adenovirus on prevention of septicemia and anemia associated with myelosuppression in mice: risk of sustained expression inducing myelofibrosis due to immunosuppression
27. Zyxin is up-regulated during megakaryocytic differentiation of human UT-7/c-mpl cells
28. A rare cause of abdominal pain: Fibromuscular dysplasia
29. Un nouveau seuil de débit salivaire pour le diagnostic de syndrome de Sjögren primaire
30. Évaluation du risque infectieux suite à l’administration de VP16 en traitement du syndrome d’activation macrophagique, série rétrospective bicentrique de 53 cas
31. Sensibilisation au syndrome d’activation macrophagique, l’expérience du service de médecine interne du CHU d’Angers
32. Thrombopoietin (TPO) knockout phenotype induced by cross-reactive antibodies against TPO following injection of mice with recombinant adenovirus encoding human TPO
33. Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment
34. Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment.
35. Murine pluripotent hematopoietic progenitors constitutively expressing a normal erythropoietin receptor proliferate in response to erythropoietin without preferential erythroid cell differentiation
36. A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression.
37. Efficacy and safety of TPO receptor agonists in treatment of ITP associated with predominantly antibody deficiencies.
38. Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX.
39. Serum ferritin/C-reactive protein ratio is a simple and effective biomarker for diagnosing iron deficiency in the context of systemic inflammation.
40. Successful treatment of JAK1-associated inflammatory disease.
41. Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients.
42. An immuno-lipidomic signature revealed by metabolomic and machine-learning approaches in labial salivary gland to diagnose primary Sjögren's syndrome.
43. SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.
44. Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged Tissues.
45. Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
46. Discordant Predictions of Extraglandular Involvement in Primary Sjögren's Syndrome According to the Anti-SSA/Ro60 Antibodies Detection Assay in a Cohort Study.
47. Multistage hematopoietic stem cell regulation in the mouse: A combined biological and mathematical approach.
48. Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold.
49. Evolution of plasma vitamin B 12 in patients with solid cancers during curative versus supportive care.
50. [Which adjuvant measures should be associated with long-term oral corticosteroid therapy in inflammatory diseases? A summary of existing French recommendations].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.